Ribosomes can produce proteins in minutes and are largely constrained to proteinogenic amino acids. Here, we report highly efficient chemistry matched with an automated fast-flow instrument for the direct manufacturing of peptide chains up to 164 amino acids long over 327 consecutive reactions. The machine is rapid: Peptide chain elongation is complete in hours. We demonstrate the utility of this approach by the chemical synthesis of nine different protein chains that represent enzymes, structural units, and regulatory factors. After purification and folding, the synthetic materials display biophysical and enzymatic properties comparable to the biologically expressed proteins. High-fidelity automated flow chemistry is an alternative for producing single-domain proteins without the ribosome.
The synthesis of a 52-member compound collection from the natural product lycorine is reported, highlighted by divergent cross-coupling and substitution strategies and an unusual ring rearrangement induced by reaction with aryne intermediates.
<p>Ribosomes produce most proteins of living cells in seconds.
Here we report highly efficient chemistry matched with an automated fast-flow
instrument for the direct manufacturing of peptide chains up to 164 amino acids
over 328 consecutive reactions. The machine is rapid - the peptide chain
elongation is complete in hours. We demonstrate the utility of this approach by
the chemical synthesis of nine different protein chains that represent enzymes,
structural units, and regulatory factors. After purification and folding, the
synthetic materials display biophysical and enzymatic properties comparable to
the biologically expressed proteins. High-fidelity automated flow chemistry is
an alternative for producing single-domain proteins without the ribosome.<i></i></p>
Rapid discovery and development of serum-stable, selective, and high affinity peptide-based binders to protein targets are challenging. Angiotensin converting enzyme 2 (ACE2) has recently been identified as a cardiovascular disease biomarker and the primary receptor utilized by the severe acute respiratory syndrome coronavirus 2. In this study, we report the discovery of high affinity peptidomimetic binders to ACE2 via affinity selection-mass spectrometry (AS-MS). Multiple high affinity ACE2-binding peptides (ABP) were identified by selection from canonical and noncanonical peptidomimetic libraries containing 200 million members (dissociation constant, KD = 19–123 nM). The most potent noncanonical ACE2 peptide binder, ABP N1 (KD = 19 nM), showed enhanced serum stability in comparison with the most potent canonical binder, ABP C7 (KD = 26 nM). Picomolar to low nanomolar ACE2 concentrations in human serum were detected selectively using ABP N1 in an enzyme-linked immunosorbent assay. The discovery of serum-stable noncanonical peptidomimetics like ABP N1 from a single-pass selection demonstrates the utility of advanced AS-MS for accelerated development of affinity reagents to protein targets.
<p>Ribosomes produce most proteins of living cells in seconds.
Here we report highly efficient chemistry matched with an automated fast-flow
instrument for the direct manufacturing of peptide chains up to 164 amino acids
over 328 consecutive reactions. The machine is rapid - the peptide chain
elongation is complete in hours. We demonstrate the utility of this approach by
the chemical synthesis of nine different protein chains that represent enzymes,
structural units, and regulatory factors. After purification and folding, the
synthetic materials display biophysical and enzymatic properties comparable to
the biologically expressed proteins. High-fidelity automated flow chemistry is
an alternative for producing single-domain proteins without the ribosome.<i></i></p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.